Two liver journals have retracted articles from a group of Irani researchers who published similar — but not quite identical — versions of the same paper some months apart.
A retraction notice in the Journal of Gastrointestinal and Liver Diseases — which bills itself as the “Official Journal of the Romanian Societies of Gastroenterology” — explains what happened: Continue reading Crise de foie: Liver journals retract duplicate biomarker pubs
Perhaps it’s appropriate given the Easter season, but we have learned that Naoki Mori, the Japanese cancer researcher who received a 10-year publishing ban from the American Society of Microbiology (ASM) for imagine manipulation, has published a new paper.
Mori, who was fired and then rehired by the University of the Ryukyus over the scandal, is listed as the senior author on the paper, “Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia,” which appears in the March issue of Biochimica et Biophysica Acta. The journal, an Elsevier title, is an umbrella for nine publications in the biosciences.
Two of Mori’s retracted articles appeared in the Elsevier journals Leukemia Research and Biochemical and Biophysical Research Communications. Continue reading Back in the saddle: After more than 30 retractions, Naoki Mori publishing again
Alirio Melendez, the former National University of Singapore researcher who has already retracted two papers in the midst of an investigation into about 70 of his publications, has had a third retracted a third.
Here’s the notice from the Journal of Cellular Physiology: Continue reading Third retraction arrives for Alirio Melendez, this one in the Journal of Cellular Physiology
Normally we’d make hay with the following notice in Acta Biochimica et Biophysica Sinica — separating the wheat from the chaff, Love and Death, and all that — but, well, it speaks for itself (sort of).
A group of researchers in China have retracted their 2011 paper on the biochemistry of chloroplast in wheat: Continue reading It “takes a long time to have these experiments redone,” so group retracts wheat paper after reader challenges
A group of French cardiology researchers have retracted a study of a potential way to rule out heart attacks, after it became clear they had used data from another study without alerting the journal.
In an unusually forthright letter accompanying the retraction of “Concomitant measurement of copeptin and high-sensitivity troponin for fast and reliable rule out of acute myocardial infarction,” originally published in Intensive Care Medicine, Bruno Riou and colleagues note: Continue reading Salami slicing and heart attacks don’t mix: Duplication, lack of transparency lead to retraction
The retraction count for Dipak Das, the resveratrol researcher whom the University of Connecticut found to have committed 145 counts of fabrication and falsification of data, has risen to eight with withdrawals by Free Radical Biology & Medicine and Free Radical Research.
The two Free Radical Biology & Medicine retractions, for “Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol” (cited 38 times, according to Thomson Scientific’s Web of Knowledge) and “Redox regulation of resveratrol-mediated switching of death signal into survival signal” (cited 32 times), are carefully detailed and read the same way: Continue reading Three more retractions for resveratrol researcher Dipak Das, in free radical journals
A while back (last June, to be precise), we wrote about a group of Japanese endocrinologists who found a creative way to up their citation counts using duplicate publication. At the time, the researchers were docked a 2004 paper in the Journal of Steroid Biochemistry & Molecular Biology that had self-plagiarized extensively from a 2003 article in Cell.
Well, skeptics of this new math take heart: The group’s publication total has fallen yet again. Turns out that 2003 paper — which has been cited 160 times, up from 144 when we checked last year, according to Thomson Scientific’s Web of Knowledge — wasn’t quite up to snuff, either.
According to the retraction notice for the article, “The Chromatin-Remodeling Complex WINAC Targets a Nuclear Receptor to Promoters and Is Impaired in Williams Syndrome:” Continue reading Cell paper, once plagiarized, pulled for dodgy figures
Rheumatology has retracted a 2011 paper with too many errors to correct.
According to the notice, the article, titled “Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia’, by Hongli Liu and colleagues at Huazhong University of Science and Technology in China, seems to have been deeply flawed: Continue reading Rheumatology retracts lupus-cancer meta-analysis over multiple errors
If you’re a rabbit and you haven’t figured out where to carry your cell phone, your front pocket is just fine.
That’s what you could reasonably infer from the retraction of a paper in the International Journal of Andrology purporting to show that mobile phones affected rabbits’ sperm counts. The notice, signed by the journal’s editor, Ewa Rajpert-De Meyts (we added links): Continue reading Rabbits needn’t worry about cell phones’ effects on their sperm count, say three retractions
It’s never a good sign when a paper has “severe” problems with its data. But when even the researchers are at a loss to explain how those problems made their way into the manuscript, well, that’s downright alarming.
Consider: The journal Clinical and Translational Allergy has retracted a 2011 article by researchers from Egypt and Finland, who have been studying the effects of vitamin C on childhood asthma. In a previous article, published in 2009 in Acta Paediatrica, members of the team reported that Continue reading Paper linking vitamin C and reduced asthma retracted after authors find “severe” problems with data